...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Free
Message: Re: Insider Selling
4
Jul 11, 2019 08:20PM

Jul 11, 2019 08:44PM
3
Jul 11, 2019 09:10PM
3
Jul 11, 2019 09:14PM
4
Jul 11, 2019 09:17PM
4
Jul 11, 2019 09:38PM
1
Jul 12, 2019 07:24AM
2
Jul 12, 2019 08:28AM
1
Jul 12, 2019 11:26AM
3
Jul 12, 2019 11:55AM
2
Jul 12, 2019 12:25PM

Thanks for highlighting.

As others have noted, he has exercised 75,000 shares in the last month, and only sold 11,800. And as said people have noted, the optics of said action are not good.

It's also an interesting development considering that he would have access to the "blinded data". I recall that some of us have been told by the company's executives that said "blinded data" looked incredible. I recall someone posted specifically about this last summer (link):

"Blinded data is also pointing in the right direction for the other end points – eGFR data “looks stunning, seeing amazing increases, unheard of”, cognitive improvement (MoCA test) data also encouraging (looking for >1.5 units improvement; anything <18 is considered Alzheimers)."


Jul 12, 2019 08:47PM
4
Jul 13, 2019 12:09PM
3
Jul 13, 2019 01:31PM
5
Jul 13, 2019 04:59PM
1
Jul 13, 2019 05:00PM
4
Jul 13, 2019 05:06PM
5
Jul 13, 2019 08:18PM
4
Jul 13, 2019 09:06PM
4
Jul 13, 2019 10:16PM
3
Jul 13, 2019 10:28PM
4
Jul 14, 2019 05:43AM
4
Jul 14, 2019 10:30AM
9
Jul 14, 2019 01:09PM
3
Jul 14, 2019 02:05PM
1
Jul 14, 2019 10:35PM
1
Jul 15, 2019 01:04AM
Share
New Message
Please login to post a reply